The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAGIO MED HLDGS INC | COM | 00534B100 | 143,742 | 110,571 | SH | SOLE | 110,571 | 0 | 0 | ||
ALUMIS INC | COM | 022307102 | 2,325,000 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
ANIKA THERAPEUTICS INC | COM | 035255108 | 6,229,472 | 588,797 | SH | SOLE | 588,797 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 12,364,800 | 1,680,000 | SH | SOLE | 1,680,000 | 0 | 0 | ||
AVITA MEDICAL INC | COM | 05380C102 | 2,060,556 | 389,519 | SH | SOLE | 389,519 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 2,745,992 | 666,503 | SH | SOLE | 666,503 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 6,916,000 | 266,000 | SH | SOLE | 266,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 30,744,000 | 12,600,000 | SH | SOLE | 12,600,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 9,872,697 | 186,418 | SH | SOLE | 186,418 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 6,423,900 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 529,381 | 1,442,061 | SH | SOLE | 1,442,061 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 3,756,997 | 2,209,998 | SH | SOLE | 2,209,998 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 40,755,000 | 2,860,000 | SH | SOLE | 2,860,000 | 0 | 0 | ||
GINKGO BIOWORKS HOLDINGS | Class A New | 37611X209 | 5,625,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 5,948,973 | 11,500,000 | PRN | SOLE | 8,000,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 4,360,350 | 3,545,000 | SH | SOLE | 3,545,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 119,258,700 | 3,905,000 | SH | SOLE | 3,905,000 | 0 | 0 | ||
IBIO INC | COM NEW | 451033708 | 285,000 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
IMMUNOME INC | COM | 45257U108 | 32,825,103 | 3,529,581 | SH | SOLE | 3,529,581 | 0 | 0 | ||
JOURNEY MEDICAL CORP | COM | 48115J109 | 682,100 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 4,556,052 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 11,877,900 | 4,110,000 | SH | SOLE | 4,110,000 | 0 | 0 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | 30,838,500 | 2,475,000 | SH | SOLE | 2,475,000 | 0 | 0 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | 2,730,630 | 239,319 | SH | SOLE | 239,319 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 14,801,600 | 1,595,000 | SH | SOLE | 1,595,000 | 0 | 0 | ||
OPUS GENETICS INC | COM | 67577R102 | 1,149,362 | 1,220,000 | SH | SOLE | 1,220,000 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 266,400 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 5,803,350 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 2,590,650 | 855,000 | SH | SOLE | 855,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 3,862,950 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 4,029,351 | 903,442 | SH | SOLE | 903,442 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 30,015,250 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
SANUWAVE HEALTH INC | COM | 80303D305 | 32,202,800 | 980,000 | SH | SOLE | 980,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 8,550,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 6,380,062 | 562,120 | SH | SOLE | 562,120 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 19,254,650 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 2,133,300 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
VIGIL NEUROSCIENCES INC | COM | 92673K108 | 7,950,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 6,428,192 | 255,087 | SH | SOLE | 255,087 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 2,232,188 | 1,924,300 | SH | SOLE | 1,924,300 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985Y108 | 2,635,500 | 210,000 | SH | SOLE | 210,000 | 0 | 0 |